Tumor biological profile of patients up to 50 years of age in an inland city of São Paulo

Authors

Keywords:

breast neoplasms, screening; immunohistochemistry

Abstract

Introduction: In Brazil, breast cancer screening is not performed in young women. However, although less frequent, the disease is generally more aggressive in this age group, with worse prognosis and refractoriness to treatment. Thus, the identification of specific subtypes by immunohistochemistry can help improve the effectiveness of treatments. Objectives: To evaluate the biological characteristics of breast tumors in patients under 50 years. Methods: This is an observational, longitudinal, retrospective study, based on data collected from medical records of the Hospital do Câncer de Franca, from January 2015 to February 2018. Results: The most frequent biological subtype was luminal B (42.5%), and the mean age of the women was 43.6 years. The most prevalent clinical staging was IIA (31%). Mastectomy with axillary drainage was the most used surgical treatment. A positive correlation was found between biological profiles and sociodemographic data, with a predominance of the luminal B subtype in women under 40 years and luminal A in those between 41 and 50 years. The mean tumor size was 4.2 cm, being larger in older and white patients. In multiparous women, the subtypes HER2 and luminal A and B stood out. Conclusion: Luminal B and luminal A biological profiles, as well as staging II and III, were the most prevalent. Mastectomy and axillary drainage were the most common surgical treatments. The employment of these procedures should be reviewed by the service in order to improve the quality of life of the patients treated, favoring the expansion of primary conservative surgeries or post-neoadjuvant chemotherapy. 

Downloads

Download data is not yet available.

References

Pinheiro AB, Lauter DS, Medeiros GC, Cardozo IR, Menezes LM, Souza RMB, et. al. Câncer de mama em mulheres jovens: análise de 12.689 casos. Rev Bras Cancerol. 2013;59(3):351-9. https://doi.org/10.32635/2176-9745.RBC.2013v59n3.500

Brazil. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil [internet]. Rio de Janeiro: Inca; 2019. 120 p. [Accessed on Nov 11, 2020]. Available at: https://www.inca.gov.b/site/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdf

Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, et al. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol. 2010;21(10):1974-81. https://doi.org/10.1093/annonc/mdq072

Abdel-Razeq H, Almasri H, Abdel Rahman F, Abdulelah H, Abu Nasser M, Salam M, et al. Clinicopathological characteristics and treatment outcomes of breast cancer among adolescents

and young adults in a developing country. Cancer Manag Res. 2019;11:9891-7. https://doi.org/10.2147/CMAR.S229337

Tang LC, Jin X, Yang HY, He M, Chang H, Shao ZM, etal. Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China. BMC Cancer. 2015;15:201. https://doi.org/10.1186/s12885-015-1207-z

National cancer institute. Surveillance, epidemiology and end results program. Cancer stat facts: female breast cancer [internet]. [Accessed on Nov. 11, 2020]. Available at: https://seer.cancer.gov/statfacts/html/breast.html

Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram- Baptiste D, Saslow D, et al. Cancer screening in the united states, 2019: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184-210. https://doi.org/10.3322/caac.21557.

Partridge AH, Pagani O, Abulkhair O, Aebi S, Amant F, Azim HA Jr, et al. First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014;23(3):209-20. https://doi.org/10.1016/j.breast.2014.03.011

Bártolo A, Santos IM, Valério E, Monteiro S. Depression and health- related quality of life among young adult breast cancer patients: the mediating role of reproductive concerns. J Adolesc Young Adult Oncol. 2020;9(3):431-435. https://doi.org/10.1089/jayao.2019.0144

Elias S, Facina G, Araujo Neto JT. Mastologia: condutas atuais. 1st ed. Nazário ACP, editor. São Paulo: Manole; 2015.

Alves HFBES; Viapiana PS; Silva KLT. Aspectos clínicos e patológicos do câncer de mama em mulheres jovens atendidas na FCecon entre 2003 e 2013. Rev Bras Cancerol. 2017;63(2):103- 9. https://doi.org/10.32635/2176-9745.RBC.2017v63n2.145

Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA. Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status. Cancer. 2009;115(21):4917-23. https://doi.org/10.1002/cncr.24573

DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438-51. https://doi.org/10.3322/caac.21583

Carvalho FM, Bacchi LM, Pincerato KM, Van de Rijn M, Bacchi CE. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil. BMC Womens Health. 2014;14:102. https://doi.org/10.1186/1472-6874-14-102

Olivier M, Bouaoun L, Villar S, Robitaille A, Cahais V, Heguy A, et. al. Molecular features of premenopausal breast cancers in Latin American women: pilot results from the PRECAMA study. PLoS One. 2019;14(1):e0210372. https://doi.org/10.1371/journal.pone.0210372

Romieu I, Biessy C, Carayol M, His M, Torres-Mejía G, Ángeles-Llerenas A, et al. Reproductive factors and molecular subtypes of breast cancer among premenopausal women in Latin America: the PRECAMA study. Sci Rep. 2018;8(1):13109. https://doi.org/10.1038/s41598-018-31393-7

Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, et al. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst. 2012;104(14):1094-101. https://doi.org/10.1093/jnci/djs264

Mandrik O, Ekwunife OI, Meheus F, Severens JLH, Lhachimi S, Uyl-de Groot CA, et al. Systematic reviews as a “lens of evidence”: determinants of cost-effectiveness of breast cancer screening. Cancer Med. 2019;8(18):7846-58. https://doi.org/10.1002/cam4.2498

Cardoso F, Loibl S, Pagani O, Graziottin A, Panizza P, Martincich L, et al. The European society of breast cancer specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012 Dec;48(18):3355- 77. https://doi.org/10.1016/j.ejca.2012.10.004

Stival RSM, Prestes ALO, Mansani FP. Câncer de mama em mulheres jovens: uma análise do estadiamento clínico inicial e dos subtipos moleculares dos tumores. Rev Bras Mastologia. 2014;24(1):17-22. https://doi.org/10.5327/Z201400010004RBM

Brasil. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. A situação do câncer de mama no Brasil: síntese de dados dos sistemas de informação[internet]. Rio de Janeiro: Inca; 2019. 85 p. [Accessed on Nov. 11, 2020]. Available at: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//a_situacao_ca_mama_brasil_2019.pdf

Moo TA, Sanford R, Dang C, Morrow M. Overview of breast cancer therapy. PET Clin. 2018;13(3):339-54. https://doi.org/10.1016/j.cpet.2018.02.006

Gentilini O, Botteri E, Rotmensz N, Toesca A, Oliveira H, Sangalli C, et al. Breast-conserving surgery in 201 very young patients (<35 years). Breast. 2010;19(1):55-8. https://doi.org/10.1016/j.breast.2009.11.001

Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27(15):2466-73. https://doi.org/10.1200/JCO.2008.19.8424

Katipamula R, Degnim AC, Hoskin T, Boughey JC, Loprinzi C, Grant CS, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27(25):4082–8. https://doi.org/10.1200/JCO.2008.19.4225

Downloads

Published

2021-04-05

How to Cite

Corregliano, M. R., Cintra, K. A., Kirchhoff, B. M., Martins, S. S., & Silva, R. T. (2021). Tumor biological profile of patients up to 50 years of age in an inland city of São Paulo. Mastology, 31, 1–6. Retrieved from https://revistamastology.emnuvens.com.br/revista/article/view/296

Issue

Section

Original Articles